Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A vial of medication and a syringe on a lab bench in a pharmaceutical setting.

Jun 5, 2026

Q&A: Why Pharma Supply Chains Are Turning to AI

Pharmaceutical supply chains are increasingly adopting AI to address significant challenges, including inaccuracies in demand forecasting and systemic inefficiencies.According to Natalia Andreyeva, vice president of market strategy at 4flow, traditional forecasting tools in the pharmaceutical sector often have a 30% to 40% error rate due to their inability to adapt to rapid changes in the environment, such as regulatory shifts and market demands. Many companies still rely on fragmented planning
A pill bottle and regulatory documents in a dimly lit office

Jun 5, 2026

Pharma compliance adapts to AI and regulation

The landscape of pharmaceutical compliance is undergoing significant transformation as industry leaders adapt to rapid regulatory changes and emerging technologies.During a recent webinar hosted by the Pharmaceutical Compliance Congress, experts highlighted the mounting challenges compliance teams face in an evolving environment. Tim Stow, global head of ethics and compliance at Galderma, noted the dual pressures of adapting to new regulations while managing traditional compliance responsibiliti
Flat silhouette of a stack of papers representing regulatory documentation burdens in healthcare.

Jun 5, 2026

Collate nears a $1 billion valuation and Harrison.ai grows

The rise of artificial intelligence in healthcare is exemplified by the recent funding success of Collate and the expansion of Harrison.ai, showcasing the transformative impact of technology in the sector.Collate, an AI startup specializing in life sciences documentation, has successfully raised $95 million, bringing its valuation close to $1 billion. Founded by Surbhi Sarna and Nate Smith, the company has developed tools that significantly reduce the burdens of regulatory and clinical trial pap
A minimalist representation of a gene and molecule symbolizing biotech collaboration.

Jun 5, 2026

BioNexus Gene Lab (Nasdaq: BGLC) pushes Malaysia–China biotech co-development model

BioNexus Gene Lab Corp. is advocating for a collaborative biotechnology model between Malaysia and China that transcends traditional trade practices.At the recent 2026 China–Malaysia Economic Cooperation Outlook Forum in Kuala Lumpur, BioNexus CEO Sam Tan emphasized the potential for a Malaysia–China precision healthcare corridor. He argued for a shift from mere product-level cooperation to a deeper model of co-development, clinical validation, and commercialization. This approach aims to levera
A scientist's hand adjusting a pipette over a petri dish in a lab

Jun 5, 2026

More leading researchers brought to the UK, while Horizon Europe performance strengthens in 2024

The UK is enhancing its position as a global hub for scientific research by attracting ten leading international researchers through the Global Talent Fund, aimed at advancing clean energy, life sciences, and advanced technologies.This initiative, which has already welcomed eight researchers, is backed by a £54 million fund to foster innovation in critical sectors aligned with the UK’s Modern Industrial Strategy. The expansion of the Global Talent visa to around 100 businesses by July will furth
A minimalist illustration of a folder and document representing administrative tasks in life sciences.

Jun 5, 2026

Collate Raises $95M to Transform Life Sciences AI

Collate has successfully secured $95 million in a recent funding round, elevating its valuation to nearly $1 billion and highlighting the growing venture capital interest in AI applications within the life sciences sector.This funding, led by Redpoint Ventures alongside other notable investors such as First Round Capital and Conviction Partners, brings Collate's total capital raised to $125 million in less than 18 months. The startup aims to address the overwhelming administrative burdens faced
A medical imaging device in a dimly lit hospital corridor

Jun 5, 2026

Philips and WellSpan Health Launch 7-Year Strategic AI and Imaging Partnership

Philips and WellSpan Health have forged a seven-year strategic partnership aimed at enhancing healthcare delivery through advanced imaging and AI technologies.This collaboration marks a pioneering step as it is the first joint innovation initiative between Philips and a U.S. community health system. Unlike traditional vendor relationships, Philips will engage directly with WellSpan to co-develop AI-driven healthcare solutions tailored for community care settings. The partnership encompasses all
MRI machine in a dimly lit hospital corridor

Jun 5, 2026

WellSpan Health & Philips Collaborate to Advance AI, Imaging & Diagnostics

WellSpan Health and Philips have formed a seven-year collaboration aimed at enhancing imaging and diagnostics technology across Central Pennsylvania and Northern Maryland.This partnership marks the first of its kind between Philips and a U.S. community health system, integrating a research agreement, joint innovation strategy, and a long-term commercial relationship. The focus will be on validating AI and digital tools designed to improve hospital efficiency, including throughput, costs, and wor
A minimalist representation of a brain and energy bolt symbolizing AI efficiency.

Jun 5, 2026

Flourish Raises $500M to Reinvent AI Efficiency

Flourish has secured $500 million in funding, elevating its valuation to $2.5 billion and highlighting investor confidence in its innovative approach to AI efficiency.The funding round was notably backed by Jeff Bezos and prominent venture firms, including GV and Lux Capital. Flourish, co-founded by Thomas Reardon and Rob Williams, aims to tackle the escalating energy demands of AI by drawing inspiration from the human brain's efficiency, which operates on only 20 to 50 watts compared to the meg
Flat illustration of a DNA plasmid and a needle-free vaccine syringe

Jun 5, 2026

First human trial backs AI-designed 'universal' vaccine

A groundbreaking clinical trial has demonstrated the potential of an AI-designed vaccine aimed at providing broad protection against all variants of the coronavirus SARS-CoV-2. Developed by DIOSynVax, a spinout from the University of Cambridge, this vaccine marks the first instance of an entirely AI-generated vaccine being tested in human subjects.The vaccine, named pEVAC-PS, utilizes a DNA plasmid-based, needle-free delivery system. It was engineered using extensive genetic data collected from
A test tube with a colorful liquid on a lab bench

Jun 5, 2026

Earendil: A Blueprint for a Multipolar Life Sciences Era

Earendil Labs' recent $787 million financing marks a pivotal moment in the evolution of life sciences, highlighting a new paradigm in AI-enabled drug discovery.This funding round, one of the largest in the sector, reflects a strategic convergence of geographic and operational strengths from various global players. Earendil, based in Delaware and Beijing, is poised to leverage European scientific expertise, American computational advancements, and China's rapid execution capabilities. This model
A minimalist illustration of a cancer cell and imaging system on a dark background.

Jun 5, 2026

AI-Powered Imaging Systems and Deep Learning Software Revolutionize Cancer Diagnostics Market Globally

The AI in cancer diagnostics market is poised for significant growth, driven by advancements in technology and increasing demand for early detection solutions.According to recent projections, the market is expected to increase from $0.79 billion in 2025 to $0.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 20.2%. This growth is attributed to the rising incidence of cancer globally, with the National Cancer Institute forecasting 2 million new cases in the U.S. by 2024 and 29